Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma
- 30 June 2000
- journal article
- Published by Elsevier in Respiratory Medicine
- Vol. 94, S42-S50
- https://doi.org/10.1016/s0954-6111(00)80149-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthmaRespiratory Medicine, 2000
- Assessing equivalence of inhaled drugsRespiratory Medicine, 1995
- GR106642X: a new, non-ozone depleting propellant for inhalersBMJ, 1995
- Incidence of acute decreases in peak expiratory flow following the use of metered-dose inhalers in asthmatic patientsEuropean Respiratory Journal, 1994
- Evaluation of fluticasone propionate (500 μg day−1) administered either as dry powder via a Diskhaler® inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 μg day−1) administered by pressurized inhalerRespiratory Medicine, 1993
- A placebo controlled trial of fluticasone propionate in asthmatic childrenEuropean Journal of Pediatrics, 1993
- Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group.Thorax, 1993
- Inhaled corticosteroids: benefits and risks.Thorax, 1992
- Paradoxical Bronchospasm After Use of Inhalation Aerosols: A Review of the LiteratureJournal of Asthma, 1991
- 328. Note: The Use of None-Parametric Methods in the Statistical Analysis of the Two-Period Change-Over DesignPublished by JSTOR ,1972